FDA applicant
Mankind Pharma Limited
FDA records 1 decision for Mankind Pharma Limited (New Delhi, IN) in 2024: 1 510(k) clearance. All are in product code CAF (Nebulizer (Direct Patient Interface)). Its devices cite 2 predicates, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Mankind Pharma Limited’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2024high 1 (2024) · low 0 (2025)2026
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2024.
Planning a device like Mankind Pharma Limited’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report